Integrating Immunotherapy and Nanotechnology in Advanced Drug Delivery Systems for Precision Cancer Therapy

This review article investigates recent advancements in drug delivery systems, with a specific emphasis on integrating nanotechnology and immunotherapy for precision cancer therapy. This review explores the design, development, and optimization of novel drug delivery platforms aimed at improving drug efficacy, minimizing side effects and enhancing patient outcomes. The synergistic interplay between nanocarriers and immunotherapeutic agents shows significant potential in addressing current challenges in cancer treatment, such as drug resistance and off-target effects. This article reviews recent preclinical and clinical studies, highlighting the transformative potential of these innovative approaches to reshape cancer therapeutics and facilitate the advent of personalized medicine in oncology. The research findings contribute to the ongoing initiatives aimed at refining the effectiveness and safety of pharmaceutical interventions, bringing us one step closer to more efficient and targeted cancer treatments.